Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II/III Study of the Safety and Efficacy of ADC189 Tablets in the Treatment of Influenza A Virus Infection/Influenza B Virus Infection in Adolescents and Adults

NCT06342921 is registered in ClinicalTrials.gov with Jiaxing AnDiCon Biotech Co.,Ltd as lead sponsor.

NCT NCT06342921
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06342921 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II/III Study of the Safety and Efficacy of ADC189 Tablets in the Treatment of Influenza A Virus Infection/Influenza B Virus Infection in Adolescents and Adults
Lead sponsor
Jiaxing AnDiCon Biotech Co.,Ltd
Phase
Phase 2/3
Overall status
Completed
Start date
December 7, 2022
Completion date
January 22, 2024
Enrollment
749 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

effect of drug, safety issues